Trastuzumab Completed Phase N/A Trials for Ductal Carcinoma In Situ Treatment

IndicationsStatusPurposePhase
CompletedTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT00496808Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast